Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SDGR
SDGR logo

SDGR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Schrodinger Inc (SDGR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
16.490
1 Day change
-3.00%
52 Week Range
23.750
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

SDGR is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some short-term technical strength, but the analyst trend is weakening, insiders are selling, and there is no strong proprietary buy signal. For an impatient investor, this is not a clear entry and I would not call it a good buy today.

Technical Analysis

SDGR closed at 16.94 after a 2.99% regular-session gain, which is constructive in the near term. MACD histogram is positive and expanding, showing improving momentum. RSI at 64.89 is moderately strong but not overbought. Moving averages are converging, which suggests the stock is still in a transition phase rather than a confirmed uptrend. Key levels: pivot 16.29, resistance 17.40 and 18.08, support 15.18 and 14.50. The price is sitting above pivot, so near-term trend is positive, but not strong enough to justify an aggressive long-term buy on technicals alone.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment looks bullish overall because both put-call ratios are low, showing more call activity than put activity. However, the setup is not extremely conviction-heavy since there is no AI Stock Picker signal and no recent SwingMax buy signal. Options activity is elevated versus average, and implied volatility is high at 98.86%, with IV percentile at 92.86, which suggests traders are pricing in significant movement. That supports interest in the stock, but it does not by itself make this a clean long-term buy.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
7

Positive Catalysts

  • ["Price closed higher on the session and is trading above the pivot level, indicating short-term momentum improvement.", "MACD is positive and expanding, which supports a constructive near-term trend.", "Options positioning is bullish, with low put-call ratios indicating call-side preference.", "Similar-pattern trend data suggests modest upside over the next week and month."]

Neutral/Negative Catalysts

  • ["Morgan Stanley cut its price target to $17 from $19 and kept Equal Weight.", "KeyBanc also lowered its target to $20 from $25, showing declining analyst expectations.", "Insiders are selling, and the selling amount has increased sharply over the last month.", "Hedge funds are neutral, with no meaningful accumulation trend.", "No AI Stock Picker signal today and no recent SwingMax signal."]

Financial Performance

No usable latest-quarter financial snapshot was provided for SDGR, so I cannot confirm current revenue or earnings growth trends from the supplied data. Because of that, there is no strong financial evidence here to support an aggressive long-term buy decision. The available data is insufficient to show a clearly accelerating fundamental story.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment has turned more cautious. Morgan Stanley lowered its target to $17 and kept Equal Weight, while KeyBanc cut its target to $20 but remained Overweight. That means Wall Street is split: there is still some upside-oriented coverage, but the target cuts show fading enthusiasm. Overall, the pros view is mixed-to-neutral rather than strongly bullish.

Wall Street analysts forecast SDGR stock price to rise
7 Analyst Rating
Wall Street analysts forecast SDGR stock price to rise
4 Buy
3 Hold
0 Sell
Moderate Buy
Current: 17.000
sliders
Low
18
Averages
21.83
High
25
Current: 17.000
sliders
Low
18
Averages
21.83
High
25
Morgan Stanley
Equal Weight
downgrade
$19 -> $17
AI Analysis
2026-05-14
Reason
Morgan Stanley
Price Target
$19 -> $17
AI Analysis
2026-05-14
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on Schrodinger to $17 from $19 and keeps an Equal Weight rating on the shares.
KeyBanc
Overweight
downgrade
$25 -> $20
2026-04-13
Reason
KeyBanc
Price Target
$25 -> $20
2026-04-13
downgrade
Overweight
Reason
KeyBanc lowered the firm's price target on Schrodinger to $20 from $25 and keeps an Overweight rating on the shares. Ahead of Q1 earnings, the firm believes the setup is largely positive, with beats likely across the group. That said, KeyBanc thinks most companies will reiterate their full-year guidance given the uncertain macro. Thematically, it believes healthcare systems are continuing to see good utilization, supporting capex/ software spend, and Pharma digital advertising environment remains choppy.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SDGR
Unlock Now

People Also Watch